Predicting warfarin dosage from clinical data: A supervised learning approach
暂无分享,去创建一个
Fan Wu | Chia-Lun Lo | Ya-Han Hu | Chun-Tien Tai | Ya-Han Hu | Fan Wu | Chia-Lun Lo | Chun-Tien Tai
[1] Janice D Nunnelee,et al. Review of an Article: The international Warfarin Pharmacogenetics Consortium (2009). Estimation of the warfarin dose with clinical and pharmacogenetic data. NEJM 360 (8): 753-64. , 2009, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.
[2] M. Rodger,et al. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping? , 2010, Journal of thrombosis and haemostasis : JTH.
[3] Gal Chechik,et al. Applying an artificial neural network to warfarin maintenance dose prediction. , 2004, The Israel Medical Association journal : IMAJ.
[4] M. Marciello,et al. Dosing practices of physicians for anticoagulation with warfarin during inpatient rehabilitation. , 2000, American journal of physical medicine & rehabilitation.
[5] Pierre Durieux,et al. Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis , 2004, BMC health services research.
[6] Sepehr Shakib,et al. Warfarin--indications, risks and drug interactions. , 2010, Australian family physician.
[7] Alexander J. Smola,et al. Support Vector Regression Machines , 1996, NIPS.
[8] Gregory W Albers,et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. , 2007, Archives of internal medicine.
[9] Lior Rokach,et al. Ensemble-based classifiers , 2010, Artificial Intelligence Review.
[10] J. Hirsh,et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[11] Padraig Cunningham,et al. Explaining the output of ensembles in medical decision support on a case by case basis , 2003, Artif. Intell. Medicine.
[12] B. Cosmi,et al. Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients , 2009, Thrombosis and Haemostasis.
[13] Hyunsoo Kim,et al. Dimension Reduction in Text Classification with Support Vector Machines , 2005, J. Mach. Learn. Res..
[14] R. Altman,et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. , 2009, The New England journal of medicine.
[15] Martin H Ellis. Artificial neural networks for anticoagulant management--think again! , 2004, The Israel Medical Association journal : IMAJ.
[16] Leo Breiman,et al. Bagging Predictors , 1996, Machine Learning.
[17] Bernard Zenko,et al. Is Combining Classifiers with Stacking Better than Selecting the Best One? , 2004, Machine Learning.
[18] Chih-Ping Wei,et al. Managing Clinical Use of High-Alert Drugs: A Supervised Learning Approach to Pharmacokinetic Data Analysis , 2007, IEEE Transactions on Systems, Man, and Cybernetics - Part A: Systems and Humans.
[19] Geoffrey E. Hinton,et al. Learning representations by back-propagating errors , 1986, Nature.
[20] B. Efron. Bootstrap Methods: Another Look at the Jackknife , 1979 .
[21] S. Sathiya Keerthi,et al. Improvements to the SMO algorithm for SVM regression , 2000, IEEE Trans. Neural Networks Learn. Syst..
[22] Mark Crowther,et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[23] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[24] E. Hylek,et al. Genetic Testing for Warfarin Dosing? Not Yet Ready for Prime Time , 2008, Pharmacotherapy.
[25] Hsinchun Chen,et al. Estimating drug/plasma concentration levels by applying neural networks to pharmacokinetic data sets , 2000, Decis. Support Syst..
[26] D. Opitz,et al. Popular Ensemble Methods: An Empirical Study , 1999, J. Artif. Intell. Res..
[27] Yasunori Sato,et al. Application of Akaike information criterion to evaluate warfarin dosing algorithm. , 2010, Thrombosis research.
[28] C. Thorn,et al. Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans , 2008, Clinical pharmacology and therapeutics.
[29] Zhenya Shen,et al. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients , 2007, European Journal of Clinical Pharmacology.
[30] Christine W. Duarte,et al. High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans , 2011, Bioinform..
[31] Geoffrey E. Hinton,et al. Learning representations by back-propagation errors, nature , 1986 .
[32] Peter Norvig,et al. Artificial Intelligence: A Modern Approach , 1995 .
[33] J. You,et al. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? , 2005, British journal of clinical pharmacology.
[34] J D Horton,et al. Warfarin therapy: evolving strategies in anticoagulation. , 1999, American family physician.
[35] D. Tatro. Drug Interaction Facts , 1990 .
[36] Edwin Setiabudi,et al. Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? , 2008, Acta medica Indonesiana.
[37] David Shaw,et al. Using Machine Learning to Prescribe Warfarin , 2010, AIMSA.
[38] David W. Aha,et al. Instance-Based Learning Algorithms , 1991, Machine Learning.
[39] Panos Deloukas,et al. The largest prospective warfarin-treated cohort supports genetic forecasting. , 2009, Blood.